Hypernatremia in Hydatid Cyst Treatment

Echinococcosis, Hepatic Clinical Trial

Official title:

Systematic Review of Hypernatremia Following Hydatid Cyst Treatment

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05090020
• Other study ID #: TrabzonKERH
• Status: Recruiting
• Start date: February 1, 2021
• Est. completion date: October 31, 2021

Study information

• Verified date: October 2021
• Source: Trabzon Kanuni Education and Research Hospital
• Contact: Aydiin Aktas
• Phone: +905308807983
• Email: aydinaktas2004[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Hypertonic saline (HS) is one of the most widely used scolocidal agents in the treatment of hydatid cysts. Hypernatremia is one of the complications associated with the use of HS. It can cause hypernatremia, acid-base disorder, impaired lung, renal, cardiac and neurological functions and even death. Therefore, caution should be exercised in the use of HS, and open technique should be preferred in surgery.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 30
• Est. completion date: October 31, 2021
• Est. primary completion date: October 15, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 7 Years to 90 Years

Eligibility

Inclusion Criteria: Patients who developed hypernatremia (plasma sodium value above 145 mmol/L) due to HS use in the treatment of hydatid cyst were included to study - Exclusion Criteria:Patients who developed hypernatremia due to other treatments were excluded from the study. -

Related Conditions & MeSH terms

• Echinococcosis, Hepatic
• Hypernatremia

Intervention

Procedure:
• Treatment
Surgery and PAIR

Locations

Country	Name	City	State
Turkey	Aydiin Aktas	Trabzon	Ortahisar

Sponsors (1)

Lead Sponsor	Collaborator
Trabzon Kanuni Education and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Prevention of hypernatreima	Hypernatremia is plasma sodium value above 145 mmol/L.	3 month